News

OsteoStrong Expands in Virginia with New Location in Tysons, Virginia

OsteoStrong, a global leader in skeletal strength conditioning, is expanding in Northern Virginia with a new location in Tysons, Virginia, offering residents a cutting-edge, drug-free solution to improve bone density, strength and overall skeletal health in just 10-minute sessions per week.

Located at 8609 Westwood Center Drive, Suite 625, Vienna, VA 22182, OsteoStrong Tysons VA is owned and operated by Mahesh Raghavan, who brings more than 25 years of experience as a corporate and startup advisor specializing in digital business strategy and human-centered design.

Unlike traditional exercise or medication-based treatments, OsteoStrong’s osteogenic loading technology stimulates bone growth and structural strength through targeted movements on specialized musculoskeletal treatment devices. The system is designed for people of all ages and activity levels, offering a fast, effective and measurable way to enhance bone health, posture, balance and overall wellness.

Seeking a smarter and more proactive approach to long-term health and longevity, Raghavan discovered OsteoStrong through Tony Robbins’ book, Life Force. Inspired by the science-backed system and recognizing a growing need for innovative wellness solutions in the Washington, D.C. metropolitan area, he decided to bring the technology to the Northern Virginia community.

“My goal is to create a trusted and welcoming environment where people can take proactive ownership of their long-term strength, mobility and vitality,” said Mahesh Raghavan. “What excites me most about OsteoStrong is seeing people become stronger than they thought possible, standing taller, moving with confidence and elevating how they experience their health.”

As awareness of bone health and longevity continues to grow, OsteoStrong is expanding its reach to meet increasing demand. The new Tysons location provides individuals throughout Northern Virginia and the D.C. metro area with an accessible and research-backed approach to improving skeletal strength and overall well-being.

“We continue to see growing interest from people who want proactive, non-invasive ways to support their long-term health,” said Kyle Zagrodzky, Founder and CEO of OsteoStrong. “Mahesh brings a thoughtful and innovative mindset to this market, and we’re proud to partner with someone so committed to delivering an exceptional member experience while helping more people prioritize skeletal health.”

OsteoStrong continues to expand internationally as more consumers seek efficient, science-backed wellness solutions focused on strength, mobility and longevity. The company’s ongoing growth reflects increasing demand for preventative health technologies that support quality of life across all age groups.

“The Tysons location represents another exciting step forward in our mission to make OsteoStrong more accessible to communities across the country,” said Jimmy Youngblood, President of OsteoStrong. “Mahesh’s leadership, professional background and passion for wellness make him an outstanding fit for the brand, and we’re thrilled to welcome him to the OsteoStrong network.”

OsteoStrong Tysons VA is now open and welcoming new members. Residents throughout Vienna, Tysons Corner and the surrounding DMV region are invited to schedule a complimentary introductory session to experience the technology firsthand.

Read more here.

Recent News

09/03/2026

Seppic announces the appointment of Virginie Cavalli as Chief Executive Officer

A subsidiary of Air Liquide Healthcare, Seppic designs, manufactures, and distributes a wide range of specialty ingredients used in cosmetics, nutraceuticals, pharmaceuticals, veterinary products, and industrial applications. Nearly 900 employees support customers in 100 countries through the company’s subsidiaries and distributor network. With a degree from EMLyon school in business and financial strategy, Virginie Cavalli

09/01/2026

Andre Marshall to join National Science Foundation; Aurali Dade named Interim Vice President for Research, Innovation, and Economic Impact

Since joining George Mason in 2021, Marshall has played a pivotal role in advancing the university’s research enterprise and entrepreneurial ecosystem and strengthening the university’s reputation as a leading public R1 institution, including launching the Grand Challenge Initiative and empowering institute-driven initiatives like Nexus234 and the Virginia Climate Center. During Marshall’s tenure, George Mason expanded research activity and strategic partnerships,

08/25/2026

United Therapeutics Corporation Announces FDA Filing Acceptance of New Drug Application for Ralinepag to Treat Pulmonary Arterial Hypertension

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that the FDA has accepted the New Drug Application (NDA) for ralinepag to treat PAH. The FDA has set a Prescription Drug User Fee Act target action date of June 24, 2027. Ralinepag has not been approved for use in any indication by the